TiumBio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	10,763	16,454	10,509	18,130	6,880
Short-Term Investments	500	-0	3,000	-	33,755
Trading Asset Securities	31,128	34,170	26,948	16,970	-
Cash & Short-Term Investments	42,391	50,624	40,457	35,100	40,635
Cash Growth	-16.26%	25.13%	15.26%	-13.62%	-40.74%
Accounts Receivable	1,596	743.01	537.39	90.8	23.44
Other Receivables	467.42	526.39	633.93	369.93	943.81
Receivables	2,075	1,318	1,171	460.73	967.24
Inventory	324.25	356.06	-	-	-
Prepaid Expenses	66.11	94.98	201.24	182.85	136.88
Other Current Assets	6,052	6,520	3,481	4,551	161.96
Total Current Assets	50,909	58,914	45,311	40,295	41,901
Property, Plant & Equipment	43,375	44,721	42,031	24,362	14,826
Long-Term Investments	1,461	899.99	23,311	24,579	46,094
Goodwill	1,326	1,326	-	-	-
Other Intangible Assets	543.71	423.44	584.69	1,072	1,324
Other Long-Term Assets	922.07	1,014	8,309	5,951	12,591
Total Assets	98,554	107,298	119,546	96,259	116,735
Accounts Payable	129.84	68.65	-	-	-
Accrued Expenses	2,312	2,999	2,461	1,970	2,537
Short-Term Debt	14,105	12,967	4,869	19,133	-
Current Portion of Long-Term Debt	3,000	-	-	-	-
Current Portion of Leases	663.6	532.26	895.1	516.79	850.28
Current Unearned Revenue	361.55	76.2	316.11	43.65	25.15
Other Current Liabilities	12,290	10,818	4,499	8,446	1,054
Total Current Liabilities	32,862	27,461	13,041	30,110	4,467
Long-Term Debt	13,400	16,400	22,655	2,708	17,787
Long-Term Leases	984.34	280.16	580.61	853.14	836.94
Long-Term Unearned Revenue	17.56	48.87	86.12	130.53	140.29
Long-Term Deferred Tax Liabilities	326.34	326.34	-	-	-
Other Long-Term Liabilities	127.78	143.33	2,031	170.87	3,185
Total Liabilities	47,718	44,659	38,393	33,972	26,416
Common Stock	14,506	13,356	12,475	12,009	11,959
Additional Paid-In Capital	49,691	169,920	169,084	145,553	144,535
Retained Earnings	-34,208	-141,848	-121,204	-103,293	-73,413
Comprehensive Income & Other	9,647	9,715	8,168	6,090	3,804
Total Common Equity	39,636	51,143	68,522	60,359	86,884
Minority Interest	-3,056	-1,713	296.33	1,249	2,746
Shareholders' Equity	50,836	62,639	81,153	62,287	90,319
Total Liabilities & Equity	98,554	107,298	119,546	96,259	116,735
Total Debt	32,153	30,180	29,000	23,211	19,474
Net Cash (Debt)	10,238	20,444	11,457	11,889	21,161
Net Cash Growth	-49.92%	78.44%	-3.63%	-43.82%	-68.57%
Net Cash Per Share	377.43	791.29	469.70	496.13	888.58
Filing Date Shares Outstanding	28.33	26.71	24.95	24.02	23.92
Total Common Shares Outstanding	28.33	26.71	24.95	24.02	23.92
Working Capital	18,047	31,453	32,270	10,185	37,434
Book Value Per Share	1398.87	1914.60	2746.48	2513.07	3632.69
Tangible Book Value	37,766	49,394	67,938	59,287	85,560
Tangible Book Value Per Share	1332.88	1849.11	2723.05	2468.43	3577.35
Land	14,856	14,856	12,783	-	-
Buildings	19,041	19,041	17,510	-	-
Machinery	15,885	15,794	14,161	11,469	8,196
Construction In Progress	-	44.8	-	14,275	5,415

Source: S&P Global Market Intelligence. Standard template. Financial Sources.